Neural Therapeutics (FRA:M6B) EPS (Basic) : €-0.01 (TTM As of Jan. 2025)

View and export this data going back to 2025. Start your Free Trial

What is Neural Therapeutics EPS (Basic)?

Neural Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Jan. 2025 was €-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2025 was €-0.01.

Neural Therapeutics's EPS (Diluted) for the three months ended in Jan. 2025 was €-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was €-0.01.

Neural Therapeutics's EPS without NRI for the three months ended in Jan. 2025 was €-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2025 was -0.01.

During the past 3 years, the average EPS without NRI Growth Rate was -26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Neural Therapeutics's highest 3-Year average EPS without NRI Growth Rate was -26.00% per year. The lowest was -141.00% per year. And the median was -83.50% per year.

Neural Therapeutics EPS (Basic) Historical Data

The historical data trend for Neural Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neural Therapeutics EPS (Basic) Chart

Neural Therapeutics Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

EPS (Basic)

-0.02

-0.01

Neural Therapeutics Quarterly Data
	Jul20	Jul21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EPS (Basic)	Get a 7-Day Free Trial										-	-	-	-	-

Neural Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Neural Therapeutics's Basic EPS for the fiscal year that ended in Jul. 2024 is calculated as

Basic EPS (A: Jul. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.448	-	0)	/	88.701
	=	-0.01

Neural Therapeutics's Basic EPS for the quarter that ended in Jan. 2025 is calculated as

Basic EPS (Q: Jan. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.078	-	0)	/	88.701
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01

Neural Therapeutics (FRA:M6B) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Neural Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Neural Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Neural Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neural Therapeutics Inc (FRA:M6B) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

NURL:Canada

Address

130 Adelaide Street, Suite 3002, Toronto, ON, CAN, M5H 3P5

Website

https://www.neuraltherapeutics.ca

Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.

Neural Therapeutics Headlines

No Headlines